These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21584843)

  • 1. The evolution of the manufacturing science and the pharmaceutical industry.
    Politis SN; Rekkas DM
    Pharm Res; 2011 Jul; 28(7):1779-81. PubMed ID: 21584843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of manufacturing conditions and facilities in the pharmaceutical industry].
    Lhoest W
    J Pharm Belg; 2005; 60(4):109-16. PubMed ID: 16429832
    [No Abstract]   [Full Text] [Related]  

  • 3. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
    Stegemann S
    Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Opinion Leaders--SMi's inaugural conference understanding physician-pharmaceutical industry relationships.
    Mason V
    IDrugs; 2008 Dec; 11(12):889-93. PubMed ID: 19051150
    [No Abstract]   [Full Text] [Related]  

  • 8. Innovation in biotechnology: current and future states.
    Woollett GR
    Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
    Roman A
    Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
    [No Abstract]   [Full Text] [Related]  

  • 10. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
    Scott B; Wilcock A
    PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence- or opinion-based pharmaceutical policy?
    Lyles A
    Clin Ther; 2004 Nov; 26(11):1922-3. PubMed ID: 15639703
    [No Abstract]   [Full Text] [Related]  

  • 12. Pfizer-Pharmacia: the smart fit for the future.
    Wiggins WP
    Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical product development and regulatory science for the 21st century: the critical path vision and its impact on health care.
    Buckman S; Huang SM; Murphy S
    Clin Pharmacol Ther; 2007 Feb; 81(2):141-4. PubMed ID: 17259935
    [No Abstract]   [Full Text] [Related]  

  • 14. Current trends in the pharmaceutical industry--a case study approach.
    Rusu A; Kuokkanen K; Heier A
    Eur J Pharm Sci; 2011 Oct; 44(3):437-40. PubMed ID: 21782941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2012 Jan; 11(1):12-3. PubMed ID: 22212669
    [No Abstract]   [Full Text] [Related]  

  • 16. Pfizer-Pharmacia: the postmerger.
    Wiggins P
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1761-3. PubMed ID: 14585052
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in the development of chiral drugs.
    Caner H; Groner E; Levy L; Agranat I
    Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394
    [No Abstract]   [Full Text] [Related]  

  • 18. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussing Tomorrow's Regulatory Risks Today.
    Junker B
    PDA J Pharm Sci Technol; 2017 Jan; 71(1):1. PubMed ID: 28174257
    [No Abstract]   [Full Text] [Related]  

  • 20. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.